RenovoRx (RNXT) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Ascendiant Capital | Maintained | Buy | $14.50 from $14.00 | Aug 28, 2026 |
| Ascendiant Capital | Maintained | Buy | $14.00 from $13.50 | Jun 1, 2026 |
| Ascendiant Capital | Maintained | Buy | $13.50 from $13.00 | Apr 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Apr 8, 2026 |
| Ascendiant Capital | Maintained | Buy | $13.00 from $12.50 | Feb 17, 2026 |
| Ascendiant Capital | Maintained | Buy | $12.50 from $12.00 | Nov 21, 2025 |
| Ascendiant Capital | Maintained | Buy | $12.00 from $11.50 | Aug 25, 2025 |
| Ascendiant Capital | Maintained | Buy | $11.50 from $11.00 | Jun 5, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | May 19, 2025 |
| Ascendiant Capital | Maintained | Buy | $11.00 from $9.00 | Apr 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $3.00 | Apr 4, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $3.00 | Mar 27, 2025 |
| Ascendiant Capital | Maintained | Buy | $9.00 from $8.25 | Dec 10, 2024 |
| Ascendiant Capital | Maintained | Buy | $8.25 from $8.00 | Sep 12, 2024 |
| Ascendiant Capital | Initiated Coverage | Buy | $8.00 | Jun 17, 2024 |
| Alliance Global Partners | Initiated Coverage | Buy | $4.00 | Feb 2, 2024 |
| Maxim Group | Downgraded | Buy → Hold | — | Nov 15, 2023 |
| Roth MKM | Maintained | Buy | $13.00 from $14.00 | Aug 18, 2023 |
Frequently asked questions
Is RNXT a buy, sell, or hold?
Analysts covering RenovoRx currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on RNXT?
On Aug 28, 2026, Ascendiant Capital maintained RenovoRx at Buy with a price target of $14.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.